EIKO Lifesciences Quarterly Results for Trading Insights

In Sept 2025, EIKO Lifesciences (EIKO) reported revenue ₹12 Cr and net profit ₹1 Cr — revenue +50.0% YoY. For annual financials, live price and key ratios, visit EIKO stock overview.

Latest Quarter Net Profit
₹1 Cr
QSept 2025
Quarterly Results

EIKO Quarterly Results — Revenue, Profit & EPS Highlights

EIKO Lifesciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with EIKO fair value to assess whether the stock is under or overvalued.

  • Revenue of ₹12 Cr in Sept 2025 (+0.0% vs Mar 2025, +50.0% vs Sept 2024)
  • Net Profit of ₹1 Cr in Sept 2025 (+0.0% vs Mar 2025)
  • EBITDA of ₹2 Cr in Sept 2025 (+0.0% vs Mar 2025)
  • Operating Margin of 15.0% in Sept 2025 (+3.0pp vs Mar 2025)
  • Earnings Per Share of ₹0.78 in Sept 2025 (-2.5% vs Mar 2025)

EIKO Lifesciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

EIKO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Jun 2024 QoQ YoY
Revenue (₹ Cr) 12 12 11 8 11 - 50.0%
Net Profit (₹ Cr) 1 1 1 0 0 - -
EBITDA (₹ Cr) 2 2 2 1 1 - -
EPS (₹) 0.78 0.80 0.66 0.22 0.29 - -
Operating Margin (%) 15.0% 12.0% 14.0% 5.0% 4.0% - -

EIKO Share Price Trend — 1-Year Movement Across Quarterly Results

EIKO Lifesciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse EIKO ownership pattern to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 8.3%
EBITDA Margin 16.7%
Operating Margin 15.0%
ROE (Annual) 7.0%

Balance Sheet Highlights

Total Assets ₹66 Cr
Total Equity ₹57 Cr
Current Assets ₹33 Cr
Current Liabilities ₹3 Cr

Cash Flow Analysis

Operating Cash Flow ₹3 Cr
Investing Cash Flow ₹-11 Cr
Financing Cash Flow ₹7 Cr
Net Cash Flow ₹-2 Cr

Current Market Data

Current Price ₹51.02
Exchange BSE
Last Updated Apr 13, 2026

EIKO vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

EIKO Lifesciences latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Sept 2025
₹138,121.06 Cr 1326.5 3,605 585 +11.9% - 16.2% 233.1
SRF
Sept 2025
₹73,317.72 Cr 2443.2 3,560 388 -16.2% - 10.9% 186.5
Coromandel Internat…
Sept 2025
₹61,764.26 Cr 2093.6 9,771 793 +78.9% - 8.1% 76.6
Linde
Sept 2025
₹61,319.36 Cr 7240.0 650 171 +7.4% - 26.3% 361.1
Fertilisers & Chemi…
Sept 2025
₹55,492.89 Cr 852.4 1,681 21 +48.8% - 1.2% 2663.6
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores